EE507 Pre-Progression Health State Utility Values From the TALAPRO-2 Clinical Trial in Patients With Metastatic Castration-Resistant Prostate Cancer Unselected for DDR Mutations

Dec 1, 2023, 00:00 AM
10.1016/j.jval.2023.09.772
https://www.valueinhealthjournal.com/article/S1098-3015(23)03902-5/fulltext
Section Title :
Section Order : 10260
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)03902-5&doi=10.1016/j.jval.2023.09.772
HEOR Topics :
Tags :
Regions :